23 May 2013
Keywords: intercell, ixiaro, je, vacc, s-p, temodal, iv
Article | 22 December 2008
Germany's Intercell AG says that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMEA) has reached ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2008
© 2013 thepharmaletter.com